CN102552765B - Medicament for treating hyperplasia of mammary glands - Google Patents

Medicament for treating hyperplasia of mammary glands Download PDF

Info

Publication number
CN102552765B
CN102552765B CN 201210013756 CN201210013756A CN102552765B CN 102552765 B CN102552765 B CN 102552765B CN 201210013756 CN201210013756 CN 201210013756 CN 201210013756 A CN201210013756 A CN 201210013756A CN 102552765 B CN102552765 B CN 102552765B
Authority
CN
China
Prior art keywords
parts
medicament
treatment
mammary glands
treating hyperplasia
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN 201210013756
Other languages
Chinese (zh)
Other versions
CN102552765A (en
Inventor
张敏
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanghai Jingyuan Investment Co Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN 201210013756 priority Critical patent/CN102552765B/en
Publication of CN102552765A publication Critical patent/CN102552765A/en
Application granted granted Critical
Publication of CN102552765B publication Critical patent/CN102552765B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to a medicament for treating hyperplasia of mammary glands. The medicament is prepared from the following bulk pharmaceuticals in parts by weight: 5-10 parts of paris polyphylla, 20-40 parts of common selfheal fruit-spike, 10-30 parts of sappan wood, 20-50 parts of indian buead, 5-15 parts of dragon's blood, 10-30 parts of common burreed rhizome and 5-10 parts of oriental waterplantain rhizome. The medicament for treating hyperplasia of mammary glands disclosed by the invention is made of natural medicaments, and has the advantages of quick response, good curative effect and freeness from toxic and side effects.

Description

A kind of medicament for the treatment of cyclomastopathy
Technical field
The present invention relates to field of medicaments, specifically, relate to a kind of medicament for the treatment of cyclomastopathy.
Background technology
Cyclomastopathy is the modal cystic hyperplasia of breast of women, and its sickness rate accounts for the first place of mastopathy.Should be the trend that rises year by year by the disease sickness rate in the last few years, the age also more and more becomes younger.Cyclomastopathy is normal breast lobule physiological hypertrophy and subinvolution, and the mammary gland normal configuration gets muddled, and belongs to pathological proliferation, it be neither inflammation a class of non-tumor is sick again.
Summary of the invention
The purpose of this invention is to provide a kind of medicine for the treatment of cyclomastopathy.
The present invention also aims to provide the preparation method of the medicine of this treatment cyclomastopathy.
In order to realize purpose of the present invention, the invention provides a kind of medicine for the treatment of cyclomastopathy, it is to be made by weight by following bulk drugs: Rhizoma Paridis 5-10 part, Spica Prunellae 20-40 part, Lignum Sappan 10-30 part, Poria 20-50 part, Sanguis Draxonis 5-15 part, rhizoma sparganic 10-30 part and Rhizoma Alismatis 5-10 part.
Preferably, it is to be made by weight by following bulk drugs: 10 parts of 8 parts of Rhizoma Paridis, 30 parts of Spica Prunellaes, 20 parts of Lignum Sappans, 30 parts, Poria, 10 parts of Sanguis Draxonis, 20 parts of rhizoma sparganic and Rhizoma Alismatis.
Use natural drug in the medicine for the treatment of cyclomastopathy of the present invention, so it have advantages of instant effect, good effect, has no side effect.
The specific embodiment
Below the invention will be further described for the description by the specific embodiment, but this is not to be limitation of the present invention, those skilled in the art are according to basic thought of the present invention, can make various modifications or improvement, but only otherwise break away from basic thought of the present invention, all within the scope of the present invention.
The preparation of embodiment 1 powder of the present invention
Get Rhizoma Paridis 80 grams, Spica Prunellae 300 grams, Lignum Sappan 200 grams, Poria 300 grams, Sanguis Draxonis 100 grams, rhizoma sparganic 200 grams and Rhizoma Alismatis 100 grams, pulverize, cross 100 mesh sieves, then add sucrose 50 grams, mixing is packed in 100 bags and get final product.
Experimental example
Choose cyclomastopathy patient 80 examples, 18~45 years old age, 18~20 years old 8 example wherein, 21~30 years old 24 example, 31~40 years old 42 example, 41~45 years old 6 example; Unmarried 13 examples, married 67 examples; Ill 34 examples of single breast, ill 46 examples of two breasts; Single-shot hypertrophy lump 28 examples, multiple hypertrophy lump 52 examples; The course of disease is the shortest 15 days, and is the longest 5 years.Outstanding behaviours is distending pain of the breast and lump in breast.
Use the powder that makes in embodiment 1, wherein one day 3 times, each one bag, 2 weeks for the treatment of are a course for the treatment of.
Criterion of therapeutical effect
Through the treatment after lump disappear fully, breast is also without pain, every inspection is normal, more than 1 year not the recidivist for the recovery from illness; After treatment, lump disappears fully, and mastalgia takes a turn for the better, and every inspection is normal, does not recur in 1 year for taking a turn for the better; After treatment, lump dwindles or the quantity minimizing, but not as good as 1/2, conscious mastalgia and tenderness all alleviate to some extent, and every inspection is normally produce effects; After treatment, the unchanged lump of the state of an illness is substantially unchanged, and pain also without obviously alleviating, is invalid.
Through the observation of a course for the treatment of is arranged, find that all patients all meets the treatment standard of recovery from illness, and do not observe obvious untoward reaction during whole treatment.
All the patient is followed up a case by regular visits to weekly after treating a course for the treatment of, continue half a year, find the sign of recurrence.

Claims (2)

1. medicament for the treatment of cyclomastopathy, it is characterized in that, it is to be made by weight by following bulk drugs: Rhizoma Paridis 5-10 part, Spica Prunellae 20-40 part, Lignum Sappan 10-30 part, Poria 20-50 part, Sanguis Draxonis 5-15 part, rhizoma sparganic 10-30 part and Rhizoma Alismatis 5-10 part.
2. the medicament for the treatment of cyclomastopathy according to claim 1, it is characterized in that, it is to be made by weight by following bulk drugs: 10 parts of 8 parts of Rhizoma Paridis, 30 parts of Spica Prunellaes, 20 parts of Lignum Sappans, 30 parts, Poria, 10 parts of Sanguis Draxonis, 20 parts of rhizoma sparganic and Rhizoma Alismatis.
CN 201210013756 2012-01-17 2012-01-17 Medicament for treating hyperplasia of mammary glands Expired - Fee Related CN102552765B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 201210013756 CN102552765B (en) 2012-01-17 2012-01-17 Medicament for treating hyperplasia of mammary glands

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 201210013756 CN102552765B (en) 2012-01-17 2012-01-17 Medicament for treating hyperplasia of mammary glands

Publications (2)

Publication Number Publication Date
CN102552765A CN102552765A (en) 2012-07-11
CN102552765B true CN102552765B (en) 2013-06-12

Family

ID=46400219

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 201210013756 Expired - Fee Related CN102552765B (en) 2012-01-17 2012-01-17 Medicament for treating hyperplasia of mammary glands

Country Status (1)

Country Link
CN (1) CN102552765B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104800733A (en) * 2015-04-24 2015-07-29 张珊珊 Traditional Chinese medicine for treating hyperplasia of mammary glands

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1931301A (en) * 2006-09-29 2007-03-21 毛志中 Chinese medicine prepn for treating mastoproliferation and its prepn process
CN101564521A (en) * 2009-05-20 2009-10-28 石振刚 External plaster for treating hyperplasia of mammary glands

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1931301A (en) * 2006-09-29 2007-03-21 毛志中 Chinese medicine prepn for treating mastoproliferation and its prepn process
CN101564521A (en) * 2009-05-20 2009-10-28 石振刚 External plaster for treating hyperplasia of mammary glands

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
中医药治疗乳腺增生病概况;陈建功等;《中医杂志》;19980228;第39卷(第02期);118-120 *
乳腺增生病中医治疗近况;黄海锋等;《湖南中医学院学报》;19960930;第16卷(第03期);72-74 *
疏肝消癖汤治疗乳腺增生症76例;黄玉桂;《河北中医》;19980315;第20卷(第02期);92 *
陈建功等.中医药治疗乳腺增生病概况.《中医杂志》.1998,第39卷(第02期),118-120.
黄海锋等.乳腺增生病中医治疗近况.《湖南中医学院学报》.1996,第16卷(第03期),72-74.
黄玉桂.疏肝消癖汤治疗乳腺增生症76例.《河北中医》.1998,第20卷(第02期),92.

Also Published As

Publication number Publication date
CN102552765A (en) 2012-07-11

Similar Documents

Publication Publication Date Title
CN102552765B (en) Medicament for treating hyperplasia of mammary glands
CN103417718B (en) Pressure-reduction and fat-eliminating tea
CN103341096B (en) Medicine for treating hyperplasia of mammary glands and preparation method thereof
CN101947263B (en) Medicament for treating neurasthenia and insomnia
CN102600408B (en) Medicine for curing hyperplasia of mammary glands
CN103920100B (en) A kind of pharmaceutical composition treating cyclomastopathy
CN105495156A (en) Herba portulacae decoction for treating haemorrhoids
CN104522630B (en) A kind of health food of sleeping
CN104547851B (en) One treats hypertensive medicine
CN102327461B (en) Medicament for treating dermatosis
CN102100778A (en) Traditional Chinese medicine composition for treating hyperplasia of mammary glands
CN105012590A (en) Mammary gland hyperplasia preventing and treating pharmaceutical composition
CN102671076B (en) Medicament for treating gout
CN102614461A (en) Spray for rapidly relieving stenocardia and preparation method thereof
CN101797330B (en) Lipid regulating and meridians activating capsule
CN102552481A (en) Traditional Chinese medicinal composition with effects of smoothing collaterals and lowering blood pressure and preparation method thereof
CN104800574A (en) Chinese drug preparation for treating coronary heart disease
CN105434678A (en) Composition for preventing and/or treating sub-health caused by using of electronic products
CN103284043A (en) Health care product with efficacy of losing weight
CN103191326B (en) Medicine preparation for treating coronary heart diseases
CN103127413A (en) Pharmaceutical preparation for treating coronary diseases
CN102755466B (en) A kind of thing that puts drops in one's ear treating acute suppurative otitis media
CN104644654A (en) Application of 20(R)-ginsenoside Rg3 in preparation of drug for treating mammary gland proliferation and the drug thereof
CN104605410A (en) Chest enlarging medicated diet prepared from five kinds of geinseng, Chinese caterpillar fungus and seafood, and preparation method of chest enlarging medicated diet
CN103893302B (en) A kind of hypertension and hyperlipemia Chinese medicine composition and its preparation method

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
ASS Succession or assignment of patent right

Owner name: TIANJIANG PHARMACEUTICAL INDUSTRY CO., LTD., JIANG

Free format text: FORMER OWNER: ZHANG MIN

Effective date: 20130801

C41 Transfer of patent application or patent right or utility model
COR Change of bibliographic data

Free format text: CORRECT: ADDRESS; FROM: 272100 JINING, SHANDONG PROVINCE TO: 214400 WUXI, JIANGSU PROVINCE

TR01 Transfer of patent right

Effective date of registration: 20130801

Address after: 214400 Jiangyin Economic Development Zone, Jiangsu, Qin Shan Road, No. 8

Patentee after: Tianjiang Pharmaceutical Industry Co., Ltd., Jiangyin

Address before: 272100 maternal and child health care hospital, Zoucheng maternal and child health care hospital, 53 Fenghuang Road, Shandong, Shandong, Zoucheng Province, China

Patentee before: Zhang Min

C41 Transfer of patent application or patent right or utility model
TR01 Transfer of patent right

Effective date of registration: 20160612

Address after: 200331 2948, room 105, 2891 lane, South Qilian Mountains Road, Shanghai, Putuo District

Patentee after: Shanghai rich medical technology Co., Ltd.

Address before: 214400 Jiangyin Economic Development Zone, Jiangsu, Qin Shan Road, No. 8

Patentee before: Tianjiang Pharmaceutical Industry Co., Ltd., Jiangyin

C41 Transfer of patent application or patent right or utility model
TR01 Transfer of patent right

Effective date of registration: 20160818

Address after: 201209 Shanghai city Pudong New Area Sichuan Road No. 6251 building 11 Room 309

Patentee after: Shanghai Jingyuan Investment Co., Ltd.

Address before: 200331 2948, room 105, 2891 lane, South Qilian Mountains Road, Shanghai, Putuo District

Patentee before: Shanghai rich medical technology Co., Ltd.

CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20130612

Termination date: 20180117